
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $138.3M | $211.7M | $212.3M | $227.4M | $224.6M | |
Revenue Growth (YoY) | 1.1% | 53.09% | 0.27% | 7.1% | -1.23% | |
Cost of Revenues | $31.7M | $50.3M | $59.3M | $68.3M | $56M | |
Gross Profit | $106.6M | $161.5M | $153M | $159.1M | $168.6M | |
Gross Profit Margin | 77.05% | 76.26% | 72.09% | 69.95% | 75.06% | |
R&D Expenses | -$5.4M | -$9.8M | -$9.1M | -$10.3M | -$7M | |
Selling, General & Admin | $5.8M | $7.9M | $20.4M | $19.4M | $18.7M | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | $83.9M | $140.4M | $159.1M | $187.3M | $177.8M | |
Operating Income | $22.7M | $21.1M | -$6M | -$28.3M | -$9.3M | |
Net Interest Expenses | $1.6M | $6.7M | -- | $4M | $5.3M | |
EBT. Incl. Unusual Items | $16.8M | $15.9M | -$2.3M | -$108.1M | -$18M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -$3.9M | $1.3M | -$4M | $83.7K | $2.3M | |
Net Income to Company | $20.7M | $14.6M | $1.6M | -$108.1M | -$20.3M | |
Minority Interest in Earnings | $50K | $57.7K | $75.6K | $256.4K | -$57.2K | |
Net Income to Common Excl Extra Items | $20.7M | $14.7M | $1.7M | -$107.9M | -$20.3M | |
Basic EPS (Cont. Ops) | $0.35 | $0.22 | $0.02 | -$1.56 | -$0.29 | |
Diluted EPS (Cont. Ops) | $0.35 | $0.22 | -$0.06 | -$1.59 | -$0.29 | |
Weighted Average Basic Share | $58.1M | $65M | $69.1M | $69.1M | $70.4M | |
Weighted Average Diluted Share | $58.1M | $65.5M | $69.1M | $69.1M | $70.4M | |
EBITDA | $24.1M | $39.5M | $27M | -$76.1M | $15.1M | |
EBIT | $18.2M | $24.2M | $2.2M | -$100M | -$9.7M | |
Revenue (Reported) | $138.3M | $211.7M | $212.3M | $227.4M | $224.6M | |
Operating Income (Reported) | $22.7M | $21.1M | -$6M | -$28.3M | -$9.3M | |
Operating Income (Adjusted) | $18.2M | $24.2M | $2.2M | -$100M | -$9.7M |
Period Ending | 2021-07-18 | 2022-07-18 | 2023-07-18 | 2024-07-18 | ||
---|---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | -- | -- | -- | -- | -- | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | -- | -- | -- | -- | -- | |
Operating Income | -- | -- | -- | -- | -- | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -- | -- | -- | -- | -- | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -- | -- | -- | -- | -- | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -- | -- | -- | -- | -- | |
Basic EPS (Cont. Ops) | -- | -- | -- | -- | -- | |
Diluted EPS (Cont. Ops) | -- | -- | -- | -- | -- | |
Weighted Average Basic Share | -- | -- | -- | -- | -- | |
Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
EBITDA | -- | -- | -- | -- | -- | |
EBIT | -- | -- | -- | -- | -- | |
Revenue (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Adjusted) | -- | -- | -- | -- | -- |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $139.1M | $209.3M | $209.5M | $227.4M | $222.1M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $31.8M | $49.7M | $58.3M | $68.3M | $55.4M | |
Gross Profit | $107.3M | $159.6M | $151.2M | $159.1M | $166.7M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -$5.4M | -$9.7M | -$9M | -$10.3M | -$6.9M | |
Selling, General & Admin | $5.9M | $7.8M | $19.9M | $19.4M | $18.4M | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | $84.7M | $139.2M | $157.3M | $187.5M | $176M | |
Operating Income | $22.7M | $20.4M | -$6.2M | -$28.4M | -$9.3M | |
Net Interest Expenses | $1.3M | $6.8M | -- | $4M | $5.2M | |
EBT. Incl. Unusual Items | $16.9M | $15.2M | -$2.4M | -$107.8M | -$17.9M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -$4.3M | $1.3M | -$3.9M | $76.5K | $2.2M | |
Net Income to Company | $21.2M | $13.9M | $1.5M | -$107.8M | -$20.2M | |
Minority Interest in Earnings | $25.4K | $76.5K | $73.5K | $256.9K | -$55.9K | |
Net Income to Common Excl Extra Items | $21.2M | $14M | $1.6M | -$107.6M | -$20.2M | |
Basic EPS (Cont. Ops) | $0.36 | $0.21 | $0.02 | -$1.55 | -$0.29 | |
Diluted EPS (Cont. Ops) | $0.36 | $0.21 | -$0.06 | -$1.59 | -$0.29 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | $24.1M | $38.6M | $26.5M | -$75.5M | $14.8M | |
EBIT | $18.2M | $23.6M | $2.1M | -$99.7M | -$9.7M | |
Revenue (Reported) | $139.1M | $209.3M | $209.5M | $227.4M | $222.1M | |
Operating Income (Reported) | $22.7M | $20.4M | -$6.2M | -$28.4M | -$9.3M | |
Operating Income (Adjusted) | $18.2M | $23.6M | $2.1M | -$99.7M | -$9.7M |
Period Ending | 2022-07-18 | 2023-07-18 | 2024-07-18 | 2025-07-18 | 2026-07-18 | |
---|---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | -- | -- | -- | -- | -- | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | -- | -- | -- | -- | -- | |
Operating Income | -- | -- | -- | -- | -- | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -- | -- | -- | -- | -- | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -- | -- | -- | -- | -- | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -- | -- | -- | -- | -- | |
Basic EPS (Cont. Ops) | -- | -- | -- | -- | -- | |
Diluted EPS (Cont. Ops) | -- | -- | -- | -- | -- | |
Weighted Average Basic Share | -- | -- | -- | -- | -- | |
Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
EBITDA | -- | -- | -- | -- | -- | |
EBIT | -- | -- | -- | -- | -- | |
Revenue (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Adjusted) | -- | -- | -- | -- | -- |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $118.1M | $88.7M | $65.5M | $47.9M | $59.9M | |
Short Term Investments | $40.8M | $45.5M | $28.8M | $14.6M | $8M | |
Accounts Receivable, Net | $57.2M | $53.7M | $78.4M | $81.3M | $63.4M | |
Inventory | $39.7M | $42.5M | $51.8M | $53.7M | $44.8M | |
Prepaid Expenses | $2.9M | $2.3M | $3.5M | $1.9M | $1.1M | |
Other Current Assets | -- | -- | -- | -- | -- | |
Total Current Assets | $276M | $243.2M | $237.8M | $206.3M | $183.5M | |
Property Plant And Equipment | $26.4M | $30M | $37.3M | $40.2M | $38.4M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $88.2M | $165.1M | $171.8M | $107M | $103.3M | |
Other Intangibles | $43.7M | $94.5M | $100.8M | $95.8M | $84M | |
Other Long-Term Assets | -- | $1.7M | $6.7M | $6.9M | $6.5M | |
Total Assets | $447.4M | $554.4M | $586.2M | $482.4M | $436.8M | |
Accounts Payable | $17.6M | $21.1M | $24.8M | $28M | $28.5M | |
Accrued Expenses | -- | -- | -- | -- | -- | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | $2.2M | $1.9M | $3.8M | $4M | $3.5M | |
Other Current Liabilities | -- | $25.5M | $28.8M | $26.2M | $29.7M | |
Total Current Liabilities | $108.8M | $79.9M | $245.6M | $252.8M | $114M | |
Long-Term Debt | $142.5M | $145.1M | $29.3K | $64.4K | $119.4M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $280.7M | $266.3M | $292.9M | $297M | $270.3M | |
Common Stock | $176K | $191.9K | $181.7K | $187.3K | $179.8K | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | $166.4M | $288M | $293.2M | $185.5M | $166.3M | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | $407.5K | $80.7K | $106.2K | -$103.1K | $206.7K | |
Total Equity | $166.8M | $288.1M | $293.3M | $185.4M | $166.5M | |
Total Liabilities and Equity | $447.4M | $554.4M | $586.2M | $482.4M | $436.8M | |
Cash and Short Terms | $158.9M | $134.1M | $94.3M | $62.6M | $67.9M | |
Total Debt | $184.2M | $151.9M | $142.5M | $163M | $140.1M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $118.1M | $88.7M | $65.5M | $47.9M | $59.9M | |
Short Term Investments | $40.8M | $45.5M | $28.8M | $14.6M | $8M | |
Accounts Receivable, Net | $57.2M | $53.7M | $78.4M | $81.3M | $63.4M | |
Inventory | $39.7M | $42.5M | $51.8M | $53.7M | $44.8M | |
Prepaid Expenses | $2.9M | $2.3M | $3.5M | $1.9M | $1.1M | |
Other Current Assets | -- | -- | -- | -- | -- | |
Total Current Assets | $276M | $243.2M | $237.8M | $206.3M | $183.5M | |
Property Plant And Equipment | $26.4M | $30M | $37.3M | $40.2M | $38.4M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $88.2M | $165.1M | $171.8M | $107M | $103.3M | |
Other Intangibles | $43.7M | $94.5M | $100.8M | $95.8M | $84M | |
Other Long-Term Assets | -- | $1.7M | $6.7M | $6.9M | $6.5M | |
Total Assets | $447.4M | $554.4M | $586.2M | $482.4M | $436.8M | |
Accounts Payable | $17.6M | $21.1M | $24.8M | $28M | $28.5M | |
Accrued Expenses | -- | -- | -- | -- | -- | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | $2.2M | $1.9M | $3.8M | $4M | $3.5M | |
Other Current Liabilities | -- | $25.5M | $28.8M | $26.2M | $29.7M | |
Total Current Liabilities | $108.8M | $79.9M | $245.6M | $252.8M | $114M | |
Long-Term Debt | $142.5M | $145.1M | $29.3K | $64.4K | $119.4M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $280.7M | $266.3M | $292.9M | $297M | $270.3M | |
Common Stock | $176K | $191.9K | $181.7K | $187.3K | $179.8K | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | $407.5K | $80.7K | $106.2K | -$103.1K | $206.7K | |
Total Equity | $166.8M | $288.1M | $293.3M | $185.4M | $166.5M | |
Total Liabilities and Equity | $447.4M | $554.4M | $586.2M | $482.4M | $436.8M | |
Cash and Short Terms | $158.9M | $134.1M | $94.3M | $62.6M | $67.9M | |
Total Debt | $184.2M | $151.9M | $142.5M | $163M | $140.1M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $20.7M | $14.6M | $1.6M | -$108.1M | -$20.3M | |
Depreciation & Amoritzation | $5.9M | $15.2M | $24.8M | $23.9M | $24.8M | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | $17.4M | -$1.3M | -$26M | -$5M | $6.2M | |
Change in Inventories | -$3.2M | -$5.6M | -$11.4M | -$3.6M | $5.4M | |
Cash From Operations | $18.3M | $35.3M | -$11M | -$7.3M | $47.4M | |
Capital Expenditures | $7.9M | $19.5M | $18.6M | $18.6M | $11.5M | |
Cash Acquisitions | -$54.7M | -$135.6M | -$18.6M | -$8.4M | -$1.6M | |
Cash From Investing | -$62.6M | -$161.8M | -$23.3M | -$10.8M | -$6.9M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $81.1M | $258.8M | $14M | $23M | $828.6K | |
Long-Term Debt Repaid | -$20.5M | -$291.6M | -$7.8M | -$8.4M | -$15M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$2M | -$2.4M | $8.9M | -$12.2M | -$5.2M | |
Cash From Financing | $57.2M | $104.6M | $15.2M | -$3.3M | -$24.8M | |
Beginning Cash (CF) | $97.3M | $113.6M | $82.6M | $66.1M | $46.9M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $13M | -$22M | -$19.2M | -$21.5M | $15.7M | |
Ending Cash (CF) | $109.7M | $92.7M | $64.4M | $46.9M | $62.3M | |
Levered Free Cash Flow | $10.4M | $15.8M | -$29.6M | -$26M | $35.9M |
Period Ending | 2021-07-18 | 2022-07-18 | 2023-07-18 | 2024-07-18 | ||
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -- | -- | -- | -- | |
Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -- | -- | -- | -- | -- | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -- | -- | -- | -- | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | -- | -- | -- | -- | -- | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -- | -- | -- | -- | -- | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -- | -- | -- | -- | -- |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $21.2M | $13.9M | $1.5M | -$107.8M | -$20.2M | |
Depreciation & Amoritzation | $5.9M | $15M | $24.4M | $23.9M | $24.5M | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | $16.5M | -$1.3M | -$25.8M | -$4.9M | $6.3M | |
Change in Inventories | -$3.1M | -$5.6M | -$11.7M | -$3.7M | $5.3M | |
Cash From Operations | $18.5M | $34.8M | -$11.5M | -$7.5M | $46.9M | |
Capital Expenditures | $8M | $19.1M | $18.2M | $18.6M | $11.4M | |
Cash Acquisitions | -$55.8M | -$137.8M | -$18.5M | -$8.4M | -$1.6M | |
Cash From Investing | -$63.8M | -$163.7M | -$23.2M | -$11M | -$6.8M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $78.7M | $256.4M | $14.1M | $23.2M | $816K | |
Long-Term Debt Repaid | -$20.8M | -$289M | -$7.8M | -$8.3M | -$14.8M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$2M | -$2.4M | $9.1M | -$12.1M | -$5.1M | |
Cash From Financing | $54.3M | $107.4M | $15.3M | -$3.1M | -$24.6M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $3.1M | -$20.8M | -$21M | -$18.1M | $15.4M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | $10.5M | $15.7M | -$29.8M | -$26.1M | $35.5M |
Period Ending | 2022-07-18 | 2023-07-18 | 2024-07-18 | 2025-07-18 | 2026-07-18 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -- | -- | -- | -- | |
Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -- | -- | -- | -- | -- | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -- | -- | -- | -- | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | -- | -- | -- | -- | -- | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -- | -- | -- | -- | -- | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -- | -- | -- | -- | -- |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.